Hidetoshi Torami

Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The private company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies.

Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom.

Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan.

Activus Pharma Co., Ltd. provides research and development services. It engages in drug development based on Activus Pure Nano-particleTechnology (APNT). The company was founded by Yasuo Aoki on October 24, 2006 and is headquartered in Tokyo, Japan.

Part of Garrett Motion, Inc., Garrett Motion Japan, Inc. is a Japanese company that manufactures aircraft engines and engine parts. The private company is based in Minato-Ku, Japan.

Sosei CVC Ltd. is a Venture Capital firm, a subsidiary of Sosei Group Corp (TK:4565). founded in 2013. Sosei CVC Ltd. is headquartered in Tokyo.

tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.